Over the past few years, the issue of whether the description of a European patent or application should be amended…
Read More
Over the past few years, the issue of whether the description of a European patent or application should be amended…
Read MoreA Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read MoreThe EPO’s Enlarged Board of Appeal (EBA) have issued their decision on G 1/23, providing further clarity to attorneys, patentees and…
Read MoreThe Unified Patent Court (UPC) allows granted European patents to be enforced or challenged centrally and for a single ruling…
Read MoreFollowing the SkyKick v. Sky decision – which we covered in an earlier article – the key takeaway was that…
Read MoreThe EPO’s Enlarged Board of Appeal (EBA) has now issued their decision on G1/24 the referral relating to claim interpretation…
Read MoreThis article was originally commissioned and published in CITMA’s online blog, May 2025 Thom Browne and Adidas: two global names…
Read MoreThe European Patent Office (EPO) has recently issued the 2024 edition of its annual Patent Index which provides a detailed overview…
Read MoreNow that we are into 2025 the European Patent Office (EPO) has recently issued the 2024 edition of its annual Patent…
Read MoreIntention to use it or lose it? Trainee trade mark attorney Joe Gargano explains that while Sky and SkyKick settled…
Read MoreApplications for registered EU designs can be filed at the EUIPO and offer a convenient, cost-effective way of obtaining design…
Read MoreThe Unified Patent Court (UPC) has issued its first decision on patent infringement by equivalence in Plant-e Knowledge B.V. &…
Read More